Effects of macrophage colony-stimulating factor on antifungal activity of neonatal monocytes against Candida albicans

Biology of the Neonate

Volumn 80, Issue 4, 2001, Pages 251-256

  Gioulekas, Elias ^a   Goutzioulis, Michael ^a   Farmakis, Christos ^a   Drossou, Vasiliki ^a   Kremenopoulos, George ^a   Tsiouris, John ^a   Roilides, Emmanuel ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

Candida albicans; Fungal immunity; Macrophage colony stimulating factor; Monocytes; Neonates

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT COLONY STIMULATING FACTOR; SUPEROXIDE;

ADULT; AGE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS IMMUNITY; HOST RESISTANCE; HUMAN; HUMAN CELL; MONOCYTE; NEWBORN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

ADULT; AGING; CANDIDA ALBICANS; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTES; PHAGOCYTOSIS; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

CANDIDA ALBICANS;

EID: 0034777128     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047152     Document Type: Article

References (49)

1. Neonatal nosocomial infections
2. Systemic Candida infections in infants in intensive care units: High incidence of central nervous system involvement
3. Disseminated fungal infections in very low birth weight infants: Clinical manifestations and epidemiology
4. Systemic candidiasis in very low birth weight infants
5. Candida. An increasingly important pathogen in the nursery
6. Neonatal candidiasis: The current challenge
7. Candida lusitaniae infection in the newborn: Case report and review of the literature
8. Risk factors associated with candidemia in the neonatal intensive care unit: A case-control study
9. Invasive candidiasis in pediatric patients: A prospective study
10. Clinical significance and immunological basis of candidal infection in immunodeficiency disorders
11. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages
12. Candidacidal mechanisms in the human neonate. Impaired IFN-γ activation of macrophages in newborn infants
13. Macrophages in resistance to candidiasis
14. Impaired production of IFN-γ by newborn cells in vitro is due to a functionally immature macrophage
15. Defective IFN-γ production in the human neonate. Dysregulation rather than abnormality
16. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation
17. In vivo effects of macrophage colony-stimulating factor on human monocyte function
18. Effects of M-CSF on antifungal activity of the mononuclear phagocytes against Aspergillus fumigatus
19. The role of immunoreconstitution in the management of refractory opportunistic fungal infections
20. Protective effect of human macrophage colony-stimulating factor on fungal infection. In vivo effect of hM-CSF on systemic candidiasis and in vitro effect of hM-CSF on macrophage activities
21. Enhancement of human monocyte function against Candida albicans by the colony stimulating factors: IL-3, GM-CSF and M-CSF
22. Effects of M-CSF on the activities of murine monocytes and peritoneal macrophages in vivo
23. Colony stimulating factor induced monocyte survival and differentiation into macrophages in serum free cultures
24. Induction of monocyte migration by recombinant M-CSF
25. Macrophage colony stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity
26. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony stimulating factor: Evidence for augmented expression of mannose receptors
27. The effect of human recombinant M-CSF on the murine mononuclear phagocyte system in vivo
28. Successful treatment of Candida osteomyelitis with fluconazole: A noncomparative study of two patients
29. Oral azole drugs as systemic antifungal therapy
30. Oral itraconazole therapy for disseminated candidiasis in low birth weight infants
31. Antifungal agents
32. Pharmacokinetics and adverse effects of amphotericin B in infants and children
33. Disseminated fungal infections in very low birth weight infants: Therapeutic toxicity
34. In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults
35. High level interleukin-12 production, but diminished interferon-gamma production by cord blood mononuclear cells
36. Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood
37. Characteristics and functional capacities of human blood granulocytes and monocytes
38. Disparate effects of interferon-γ and tumor necrosis factor-α on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro
39. Phagocytosis-associated functions in neonatal-derived macrophages
40. Human neonatal monocyte-derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production
41. Oxidative metabolism in cord blood monocytes and monocyte-derived macrophages
42. Decreased granulocyte-macrophage colony stimulating factor production by human neonatal blood mononuclear cells and T cells
43. In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults
44. Defective oxidative metabolic responses of neutrophils from stressed neonates
45. Macrophage colony-stimulating factor enhances the capacity of murine macrophages to secrete oxygen reduction products
46. Monocytes and macrophages
47. Phagocyte functions and defects. A ten year update
48. Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia
49. Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy